Pharmatest offers translational models to test the efficacy of your oncology drug candidates. Our comprehensive oncology services include in vitro assays, in vivo efficacy models, radiotherapy testing service and ex vivo imaging technologies.
Pharmatest is a CRO specialized in orthotopic and metastasis models, and as bone experts we have special expertise in bone metastasis models. The major advantage of these models is the proper tissue microenvironment that is known to affect tumor properties and drug resistance. This increases substantially the clinical relevance and predictivity over traditionally used subcutaneous models that lack the proper microenvironment.
The following table lists cancer cell lines that are available in Pharmatest for orthotopic and/or metastasis models.